Abstract submissions will be open August 13–September 26, 2024. Late-breaking abstract submissions in the research and industry-supported categories will be accepted from December 3, 2024–January 7, 2025. 

Detailed abstract information, submission information, and an abstract template will be available soon! 

• General (combines the previous categories of Advanced Practice, Clinical Practice, Leadership, Management/Staff Education, Quality Improvement, and Radiation) 
• Research (Abstracts submitted to the research category must be rigorous research studies, not evidence-based practice or quality improvement projects.)
• Industry-supported  

The primary author must be a licensed healthcare individual and have knowledge of the information being submitted. Abstracts may have up to six authors, but only the primary author receives communication from ONS and is responsible for uploading all information. If the primary author is unable to present an accepted abstract, another person may present in their place; however, the primary author remains the primary contact and is fully responsible for meeting all deadlines and notifying the alternate presenter of any communications received from ONS. This author also will be listed as the first/primary author in the online publication of the abstract in the Oncology Nursing Forum. Please note that authors cannot be changed once the abstract deadline has passed. 

Yes, you can submit a trial in progress. However, you must have enough information to answer all scoring criteria questions. Trials-in-progress abstracts are only accepted as posters, not oral presentations, if scored high enough to make the cut score.

No, ONS does not accept abstracts that have already been presented at another national meeting or previously published. However, if the abstract has been presented at a local conference or has different endpoints or results than what was previously presented nationally, it may be submitted for ONS Congress.   

Abstract notifications for the general call will be sent by November 20, 2024. Notifications for late-breaking abstracts will be sent by February 3, 2025. You may need to check your junk or spam mailbox; the email will come from ons@confex.com.   

All abstracts are scored and then ranked. A panel then determines a cut score for oral abstracts, posters, and declined abstracts. Abstracts are accepted for oral presentation based on score only and are placed into sessions with other similarly themed abstracts. Posters are presented during moderated poster sessions and are available in the app and on the ONS website. Please note that you can submit your abstract for poster presentation only if desired.  All accepted abstracts are published online in the Oncology Nursing Forum.  

Once an abstract is accepted for presentation at ONS Congress, it may not be presented at another conference until the end of ONS Congress. You may withdraw your abstract from the other conference, or, if desired, from ONS Congress.   

No. Once the deadline for submission has passed, no changes can be made to authorship. 

No. Once you have submitted your abstract and it has been accepted, you are not able to make any changes. However, if accepted, the information in your presentation may be changed, especially if you have new results from your project or research.    

Abstracts can be withdrawn through the abstract submission center prior to the submission deadline. After the submission deadline, please email conferences@ons.org for any withdrawal requests.